Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Arcutis Biotherapeutics (ARQT) Gains from Investment Securities (2020 - 2025)

Historic Gains from Investment Securities for Arcutis Biotherapeutics (ARQT) over the last 3 years, with Q3 2025 value amounting to $3.2 million.

  • Arcutis Biotherapeutics' Gains from Investment Securities rose 75428.57% to $3.2 million in Q3 2025 from the same period last year, while for Sep 2025 it was $2.7 million, marking a year-over-year increase of 62432.43%. This contributed to the annual value of $3.6 million for FY2020, which is 82506.39% up from last year.
  • Per Arcutis Biotherapeutics' latest filing, its Gains from Investment Securities stood at $3.2 million for Q3 2025, which was up 75428.57% from -$490000.0 recorded in Q3 2024.
  • Arcutis Biotherapeutics' 5-year Gains from Investment Securities high stood at $3.2 million for Q3 2025, and its period low was -$490000.0 during Q3 2024.